Psychedelic Alpha News Today

Nearly fifteen months after Colorado voters approved the Natural Medicine Health Act, the public got its first glimpse of draft rules that will govern the regulated psychedelics program...

FDA and Reagan-Udall Foundation are hosting a virtual public meeting on psychedelic research titled Advancing Psychedelic Clinical Study Design, which aims to explore empirical approaches to address issues in drug development.

Across California, dozens of medical studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.

Across California, dozens of such studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.

Across California, dozens of such studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.

Across California, dozens of such studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.

Across California, dozens of such studies are in limbo thanks to a little-known government panel that monitors research on federally restricted drugs and addiction treatment.

Dozens of California studies on psychedelics or addiction treatment that need to be vetted by a little-known government panel are now in limbo. Some scientists want to abolish the panel entirely.

Dozens of California studies on psychedelics or addiction treatment that need to be vetted by a little-known government panel are now in limbo. Some scientists want to abolish the panel entirely.

The co-founders of PPA discuss the importance of advocacy work at this point in the development of the psychedelic medicine industry to help cement pharmacist’s role in the continuum of care.